abstract |
The present invention relates to the use of compounds of formulae I-VI for producing a drug for treating acute and chronic lung diseases, such as Respiratory Distress Syndrome [acute lung injury (ALI), acute respiratory distress syndrome (ARDS)], and for treating COPD. |